21st January 2022 | Pharma Updates
Indian Pharma Companies Boost Drug Discovery Effort
India’s health ministry has declared that a policy to mount research in the pharma sector is underway.
Laurus, 9 others are picked to supply Covid drug
United Nations-backed Medicines Patent Pool has entered into sublicense agreements with ten Indian pharma companies for manufacturing and supplying molnupiravir to 105 countries.
La Renon buys Stake In Enaltec Labs
Pharma firm has bought 51% stake in Enaltec. The deal is priced at Rs 180- 200 cr, people aware of the matter said.
Novo Nordisk presents Anti-diabetic Pill
The drug company had invested around 15 years of research to bring the oral formulation of semaglutide in India.
Glenmark Pharma signs pact with Lotus International
According to the agreement, now Lotus will manufacture and supply Ryaltris.
Big Pharma All Set for Third Wave
With the third Covid wave coming in, Cipla, Emcure, Aurobindo and Health Biotech Ltd. are ready to deliver Covid medicines across the country.
Slump In Sales of Remdesivir
Rs 12 cr worth of Remdesivir was sold last month. Medical doctors say mild Covid cases and awareness is the reason.
